These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Severe camptocormia due to myositis of paraspinal muscles as an early manifestation of Parkinson's disease. Whittaker K; Schroeter N; Rijntjes M; Guggenberger K; Lambeck J; Fritsch B; Weiller C; Meyer PT; Doostkam S; Klebe S Parkinsonism Relat Disord; 2018 Jan; 46():95-97. PubMed ID: 29174169 [No Abstract] [Full Text] [Related]
27. Upright posture in parkinsonian camptocormia using a high-frame walker with forearm support. Schroeteler FE; Fietzek UM; Ziegler K; Ceballos-Baumann AO Mov Disord; 2011 Jul; 26(8):1560-1. PubMed ID: 21520281 [No Abstract] [Full Text] [Related]
28. Camptocormia as presenting manifestation of a spectrum of myopathic disorders. Ghosh PS; Milone M Muscle Nerve; 2015 Dec; 52(6):1008-12. PubMed ID: 25900737 [TBL] [Abstract][Full Text] [Related]
29. Validity of the wall goniometer as a screening tool to detect postural abnormalities in Parkinson's disease. Tinazzi M; Gandolfi M; Artusi CA; Lanzafame R; Zanolin E; Ceravolo R; Capecci M; Andrenelli E; Ceravolo MG; Bonanni L; Onofrj M; Telese R; Bertolotti C; Polverino P; Manganotti P; Mazzucchi S; Giannoni S; Vacca L; Stocchi F; Casali M; Zibetti M; Lopiano L; Fasano A; Geroin C Parkinsonism Relat Disord; 2019 Dec; 69():159-165. PubMed ID: 31704143 [TBL] [Abstract][Full Text] [Related]
30. MRI findings in camptocormia. Gillardin P; Lemmerling M; Van der Linden C Acta Neurol Belg; 2014 Dec; 114(4):315-7. PubMed ID: 24638857 [No Abstract] [Full Text] [Related]
31. Continuous mobile measurement of camptocormia angle using four accelerometers. Naderi Beni K; Knutzen K; Kuhtz-Buschbeck JP; Margraf NG; Rieger R Med Biol Eng Comput; 2024 Jun; ():. PubMed ID: 38926332 [TBL] [Abstract][Full Text] [Related]
32. Camptocormia as an onset symptom of myasthenia gravis. Sato T; Natori T; Hata T; Yamashiro N; Shindo K; Takiyama Y Neurol Sci; 2017 Mar; 38(3):515-516. PubMed ID: 27812759 [No Abstract] [Full Text] [Related]
33. A Case Report of Camptocormia Coinciding With Olanzapine Use. González-Pablos E; Valles-de la Calle JM; Iglesias-Santa Polonia F; Cámara Barrio S J Clin Psychopharmacol; 2016 Apr; 36(2):183-4. PubMed ID: 26872119 [No Abstract] [Full Text] [Related]
34. Deep brain stimulation as a treatment for Parkinson's disease related camptocormia. Chieng LO; Madhavan K; Wang MY J Clin Neurosci; 2015 Oct; 22(10):1555-61. PubMed ID: 26321306 [TBL] [Abstract][Full Text] [Related]
35. Camptocormia: don't forget muscle disease in the movement disorder clinic. Doherty KM; Silveira-Moriyama L; Giladi N; Bhatia KP; Parton M; Lees AJ J Neurol; 2012 Aug; 259(8):1752-4. PubMed ID: 22349871 [No Abstract] [Full Text] [Related]
36. Effect of neurostimulation on camptocormia in Parkinson's disease depends on symptom duration. Schulz-Schaeffer WJ; Margraf NG; Munser S; Wrede A; Buhmann C; Deuschl G; Oehlwein C Mov Disord; 2015 Mar; 30(3):368-72. PubMed ID: 25678310 [TBL] [Abstract][Full Text] [Related]
37. Camptocormia as presenting sign in dementia with Lewy bodies. Gavrylova N; Limousin N; Belin J; de Toffol B; Praline J Clin Neurol Neurosurg; 2013 Nov; 115(11):2397-8. PubMed ID: 24099692 [No Abstract] [Full Text] [Related]